Evidence map›Paper›PMID 38472452›Full record

ArticleScientific reports2024

Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD).

Talip Yiğit, Naim Ata, Murat Dinçer, M Mahir Ülgü, Şuayip Birinci, M Okan Ayvalı

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Talip YiğitFaculty of Economics and Administrative Sciences, Istanbul 29 Mayıs University, Ümraniye, İstanbul, Turkey. yigitt@29mayis.edu.tr.ORCID http://orcid.org/0000-0003-4195-9149
Naim AtaGeneral Directorate of Health Information System, Turkish Ministry of Health, Ankara, Turkey.ORCID http://orcid.org/0000-0001-6947-2821
Murat DinçerFaculty of Economics and Administrative Sciences, Istanbul 29 Mayıs University, Ümraniye, İstanbul, Turkey.ORCID http://orcid.org/0000-0001-7276-8738
M Mahir ÜlgüGeneral Directorate of Health Information System, Turkish Ministry of Health, Ankara, Turkey.ORCID http://orcid.org/0000-0003-0825-1851
Şuayip BirinciTurkish Ministry of Health, Ankara, Turkey.ORCID http://orcid.org/0000-0001-8104-6198
M Okan AyvalıGeneral Directorate of Health Information System, Turkish Ministry of Health, Ankara, Turkey.ORCID http://orcid.org/0000-0002-0116-5152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive research into dementia has more recently honed in on several key areas. These areas include the advancement of techniques such as the accumulation of amyloid-β and tau proteins, the monitoring of cerebral hypometabolism rates etc. The primary objective of this study is to explore the intricate interplay between Alzheimer's disease (AD)-other dementias (D) and various chronic illnesses in terms of time, intensity, and connectivity. In this context, we retrospectively examined data of 149,786 individuals aged 65 and above who received diagnoses of AD and D in the year 2020. At first, logistic regression (LR) analysis has been made with "sex", "age" and "foreigner" (citizenship status) independent variables for AD and D. The LR models shows that while "sex" and "age" variables have a small rate on the risk of developing AD/D, it is detected that being a foreigner increase the risk of AD and D as 69.8% and 88.5% respectively. Besides, the LR models have middle-level success prediction rate for both of the two dependent variables. Additionally, we used the parallel coordinates graphs method within the R Studio to visualize their relationships and connections. The findings of this investigation strongly suggest that AD/D don't stand as isolated conditions, but rather stem from intricate interactions and progressive processes involving diverse chronic diseases over time. Notably, ailments including hypertension, coronary artery disease, diabetes, hyperlipidemia, and psychological disorders, contribute substantially to the emergence of both AD and D. This study highlights that the fight against AD/D can only be possible with next-generation prophylactic interventions that can predict and manage risks. Such an approach holds the potential to potentially lower AD and dementia to levels that are amenable to treatment.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBiomarkersHumansRetrospective StudiesRisk Managementtau ProteinsTurkeyAmyloid beta-PeptidesBiomarkerstau ProteinsAlzheimerChronic diseasesConnectivityDementia

Identifiers

PMID38472452
PMCPMC10933367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.